NEA Partners 15, L.P.'s Net Worth

$812 Million

Who is NEA Partners 15, L.P.?

NEA Partners 15, L.P. has an estimated net worth of $812 Million. This is based on reported shares across multiple companies, which include Desktop Metal, Inc., Cascadian Therapeutics, Inc., Arcellx, Inc., Robinhood Markets, Inc., Nkarta, Inc., Berkshire Grey, Inc., Bright Health Group Inc., AVEO PHARMACEUTICALS, INC., IonQ, Inc., Nightstar Therapeutics plc, Reneo Pharmaceuticals, Inc., Inozyme Pharma, Inc., Millendo Therapeutics, Inc., Eargo, Inc., Annexon, Inc., ARCA biopharma, Inc., Senti Biosciences, Inc.\, and Achaogen Inc.

SEC CIK

NEA Partners 15, L.P.'s CIK is 0001640031

Past Insider Trading and Trends

2018 was NEA Partners 15, L.P.'s most active year for acquiring shares with 26 total transactions. NEA Partners 15, L.P.'s most active month to acquire stocks was the month of July. 2021 was NEA Partners 15, L.P.'s most active year for disposing of shares, totalling 24 transactions. NEA Partners 15, L.P.'s most active month to dispose stocks was the month of July. 2021 saw NEA Partners 15, L.P. paying a total of $87,118,710.00 for 208,503,857 shares, this is the most they've acquired in one year. In 2019 NEA Partners 15, L.P. cashed out on 6,662,532 shares for a total of $169,894,566.00, their largest year based on trade value.